Luis Marsano, MD
Basic profileLuis Marsano is a Gastroenterology physician affiliated with University of Louisville. OpenAlex indexes 83 publications with 4,131 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20253 payments$138
- Mallinckrodt Hospital Products Inc.Program year20251 payment$126
- Madrigal PharmaceuticalsProgram year20251 payment$125
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
42.5%Proton pump inhibitor10.2%Pantoprazole Sodium59%Omeprazole34%Nexium6%Part D<11 patientsRifamycin Antibacterial9.5%Xifaxan100%Part D≥28 patients+ 10 more classes in this area
Cardiovascular
39.7%Beta blocker16.8%Carvedilol91%Nadolol9%Part D<11 patientsStatin6.5%Simvastatin61%Atorvastatin Calcium39%Part D≥17 patients+ 5 more classes in this area
Cancer & immunology
11.1%Calcineurin inhibitor6.2%Tacrolimus76%Envarsus Xr24%Part D<11 patientsPurine Antimetabolite4.2%Azathioprine100%Part D≥16 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1999–2002 per NIH RePORTER. The latest:
- PEGYLATED-IFN COMPARED TO STANDARD REGIMAN OF ROFERON -A FOR HEPATITIS C
University of Kentucky
FY2002$73,467M01RR002602 - PEGYLATED-IFN COMPARED TO STANDARD REGIMAN OF ROFERON -A FOR HEPATITIS C
University of Kentucky
FY2001$73,467M01RR002602
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Slaughter, MD
University of Louisville
Shiao Woo, MD
University of Louisville
Matthew Cave, MD
University of Louisville
David Tollerud, MD
University of Louisville
Charles Rice, MD
The Rockefeller University
Jean-Frederic Colombel, MD
Icahn School of Medicine at Mount Sinai
Edward Loftus, MD
Mayo Clinic Rochester
Kris Kowdley, MD
Washington State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”